Trials / Completed
CompletedNCT03528967
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
Enoxaparine en PREvention Des insuffiSAnces Placentaires Chez Les Femmes eNCEintes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Les Laboratoires des Médicaments Stériles · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of the effectiveness of Enoxaparin, at a preventive dose, combined with Aspirin treatment versus Aspirin only treatment in reducing placental insufficiency in pregnant women.
Detailed description
Randomized, prospective, monocentric, open-label comparative study with two parallel groups (Enoxaparin, at a preventive dose, combined with Aspirin versus Aspirin alone), with the main objective being to evaluate the effectiveness of enoxaparin, at a preventive dose, in reducing placental insufficiency during pregnancy in pregnant women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enoxaparin 40 mg / 0.4 mL Prefilled Syringe | |
| DRUG | Aspirin 100 mg Oral Tablet, Enteric Coated |
Timeline
- Start date
- 2013-10-23
- Primary completion
- 2018-07-31
- Completion
- 2018-07-31
- First posted
- 2018-05-18
- Last updated
- 2020-07-02
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT03528967. Inclusion in this directory is not an endorsement.